228 related articles for article (PubMed ID: 23869563)
1. Implementation of risk stratified antibiotic therapy for neutropenic fever: what are the risks?
Wierema J; Konecny P; Links M
Intern Med J; 2013 Oct; 43(10):1116-24. PubMed ID: 23869563
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
[TBL] [Abstract][Full Text] [Related]
3. Management of febrile neutropenia in an acute oncology service.
Sammut SJ; Mazhar D
QJM; 2012 Apr; 105(4):327-36. PubMed ID: 22080099
[TBL] [Abstract][Full Text] [Related]
4. Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful?
Gunderson CC; Farrell R; Dinh BC; Thomas ED; Vesely SK; Lauer JK; Kao L; Chopra S; McMeekin DS; Moore KN
Gynecol Oncol; 2013 Sep; 130(3):411-5. PubMed ID: 23791827
[TBL] [Abstract][Full Text] [Related]
5. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
Chamilos G; Bamias A; Efstathiou E; Zorzou PM; Kastritis E; Kostis E; Papadimitriou C; Dimopoulos MA
Cancer; 2005 Jun; 103(12):2629-35. PubMed ID: 15856427
[TBL] [Abstract][Full Text] [Related]
6. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
8. Neutropenic fever: one institution's quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy.
Baltic T; Schlosser E; Bedell MK
Clin J Oncol Nurs; 2002; 6(6):337-40. PubMed ID: 12434465
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
10. Implementation of an evidence-based order set to impact initial antibiotic time intervals in adult febrile neutropenia.
Best JT; Frith K; Anderson F; Rapp CG; Rioux L; Ciccarello C
Oncol Nurs Forum; 2011 Nov; 38(6):661-8. PubMed ID: 22037329
[TBL] [Abstract][Full Text] [Related]
11. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
[TBL] [Abstract][Full Text] [Related]
13. [Empirical antibiotic therapy in febrile neutropenic patients with acute leukemia].
Yabe H; Nakamura F; Ishikawa T; Nagai K; Nakayama S
Rinsho Ketsueki; 1989 May; 30(5):644-9. PubMed ID: 2795878
[TBL] [Abstract][Full Text] [Related]
14. Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia.
Donohue R
Oncol Nurs Forum; 2006 Nov; 33(2):347-52. PubMed ID: 16518450
[TBL] [Abstract][Full Text] [Related]
15. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
Cherif H; Johansson E; Björkholm M; Kalin M
Haematologica; 2006 Feb; 91(2):215-22. PubMed ID: 16461306
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
[TBL] [Abstract][Full Text] [Related]
17. Prospective audit of treatment of paediatric febrile neutropenia in Australasia.
Chamberlain JD; Smibert E; Skeen J; Alvaro F
J Paediatr Child Health; 2005 Nov; 41(11):598-603. PubMed ID: 16398846
[TBL] [Abstract][Full Text] [Related]
18. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
Kern WV; Marchetti O; Drgona L; Akan H; Aoun M; Akova M; de Bock R; Paesmans M; Viscoli C; Calandra T
J Clin Oncol; 2013 Mar; 31(9):1149-56. PubMed ID: 23358983
[TBL] [Abstract][Full Text] [Related]
19. How prompt is prompt in daily practice? Earlier initiation of empirical antibacterial therapy for the febrile neutropenic patient.
van Vliet M; Potting CM; Sturm PD; Donnelly JP; Blijlevens NM
Eur J Cancer Care (Engl); 2011 Sep; 20(5):679-85. PubMed ID: 21771130
[TBL] [Abstract][Full Text] [Related]
20. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]